))
A Discussion with George Haywood: Biotech Investing, Synaptogenix & Petros
Manage episode 337249291 series 3380517
Content provided by Encode Ideas, L.P., Encode Ideas, and L.P.. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Encode Ideas, L.P., Encode Ideas, and L.P. or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
An interview with George Haywood, a well-known investor, where we discuss his perspective on biotech investing. During the interview, we cover some of George's previous biotech successes, including AVI Biopharma / Sarepta, Martek & Amarin, and his current favorite biotech names, Synaptogenix & Petros.
Companies discussed during the podcast;
- Synaptogenix, Inc. (Nasdaq: SNPX)
- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI)
- Sarepta Therapeutics, Inc. (Nasdaq: SRPT)
- Cassava Sciences, Inc. (Nasdaq: SAVA)
- Biogen Inc. (Nasdaq: BIIB)
- Pfizer Inc. (NYSE: PFE)
- Amarin Corporation plc (Nasdaq: AMRN)
7 episodes
Share
